ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1618	National Cancer Institute	Html	en	Late Effects of Treatment for Childhood Cancer (PDQ®)–Patient Version	The treatment of cancer may cause health problems (late effects) for childhood cancer survivors months or years after successful treatment has ended. Get information about the long-term physical, psychological and social effects of treatment for childhood cancer in this expert-reviewed summary.	childhood cancers 0.431043 cancer treatment 0.371211 body 0.373967 childhood cancer survivors 0.770496 chemotherapy 0.372336 PDQ cancer information 0.35879 total-body irradiation 0.354372 ovarian late effects 0.364333 bile duct 0.348106 talk 0.386582 chest radiation treatment 0.353115 kidney late effects 0.373747 joint late effects 0.365129 cancer information summary 0.349224 stem cell transplant 0.480939 pancreatic late effects 0.367016 heart 0.364096 symptoms 0.373794 health problems 0.529948 tests 0.430651 primary cancer diagnosis 0.352818 radiation therapy 0.438948 following 0.347799 hormone replacement therapy 0.348511	late effects 0.94258 treatment 0.571093 blood vessel 0.385075 primary cancer 0.359907 signs 0.42599 related health problems 0.511763 procedures 0.374731 National Cancer Institute 0.350345 spinal cord 0.453656 disease 0.351393 breast cancer risk 0.350432 breast cancer 0.372761 brain tumor 0.349819 thyroid late effects 0.395111 brain 0.380353 doctor 0.354325 radiation treatment 0.379126 radiation 0.476283 acute lymphoblastic leukemia 0.349699 health habits 0.363956 neuroendocrine late effects 0.359016 high blood pressure 0.347712 nonmelanoma skin cancer 0.356812 lung late effects 0.390136	CLICK HERE
1622	National Cancer Institute	Html	en	PC-SPES (PDQ®)–Health Professional Version	Expert-reviewed information summary about the use of PC-SPES as a treatment for prostate cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	AI prostate cancer 0.303125 herbal supplement PC-SPES 0.226052 androgen receptor 0.217805 United States 0.217375 AI human prostate 0.265687 tumor cell lines 0.239745 prostate cancer cell 0.651484 cell growth 0.337694 PC-SPES mixture 0.233921 human cancer cells 0.227728 cancer cell lines 0.814613 active agents 0.216957 cell cycle arrest 0.28032 human ovarian cancer 0.210983 PC-SPES 0.565565 metastatic prostate cancer 0.246109 human breast cancer 0.222738 prostate cancer model 0.251984 prostate specific gene 0.222494 PSA levels 0.422352 Prostate Cancer Treatment 0.30307 LNCaP prostate cancer 0.263951 human prostate LNCaP 0.252103 aggregate PC-SPES mixture 0.22369	prostate cancer cells 0.283954 cell cycle effects 0.221846 cell cycle 0.301026 Abstract 0.225583 colon cancer growth 0.213185 DU-145 prostate cancer 0.299116 prostate specific antigen 0.22926 prostate cancer patients 0.5128 PSA expression 0.28316 hormone-insensitive prostate cancer 0.250196 vitro 0.242733 vitro estrogenic activity. 0.21527 LNCaP cells 0.250769 prostate cancer 0.975741 effects 0.268243 pretreatment PSA levels 0.220575 Cancer Lett 0.216432 reduced PSA expression 0.210327 serum PSA levels 0.222831 human cancer cell 0.295651 Scutellaria baicalensis 0.227162 PC-SPES capsules 0.218201 human prostate cancer 0.330615	CLICK HERE
1649	National Cancer Institute	Html	en	Aromatherapy and Essential Oils (PDQ®)–Patient Version	Expert-reviewed information summary about the use of aromatherapy and essential oils to improve the quality of life of cancer patients.	PDQ Aromatherapy 0.51751 cancer treatment 0.518478 modern aromatherapy 0.502296 certain essential oils 0.545828 aromatherapy training 0.496531 PDQ cancer information 0.582174 Cancer Complementary 0.49782 hormone -like effects 0.496783 clinical trials 0.646919 cancer information summary 0.54045 aromatherapy massage 0.496545 alternative cancer therapies 0.488792 clinical trial 0.515897 CAM cancer research 0.479249 patients 0.520207 cancer patients 0.499565 Aromatherapy products 0.529674 bergamot essential oil 0.494855 literature discuss aromatherapy 0.518185 NCI PDQ cancer 0.50787 cancer information database 0.486869 aromatherapy 0.710126 international aromatherapy programs 0.515466 Therapies Editorial Board 0.490712	essential oils 0.964677 cancer information 0.591001 treatment 0.540034 Complementary Therapies Editorial 0.514222 Drug Administration 0.547203 Cancer Information Specialist 0.481775 Aromatherapy research 0.515581 tree essential oils 0.64448 Cancer Information Service 0.537651 tree essential oil 0.496279 Antibacterial essential oils 0.531896 National Cancer Institute 0.639762 alternative medicine 0.561892 standard aromatherapy certification 0.518782 term aromatherapy 0.502247 orange essential oil 0.494346 aromatherapy courses 0.496618 tea tree 0.549957 cancer clinical trials 0.48888 alternative therapies 0.505894 ginger essential oil 0.493305 cancer information summaries 0.487611 cancer 0.667969 Holistic Aromatherapy 0.506338	CLICK HERE
1661	National Cancer Institute	Html	en	Antineoplastons (PDQ®)–Health Professional Version	Expert-reviewed information summary about antineoplastons as a treatment for people with cancer.	various tumor suppressor 0.673325 high-risk pediatric patients 0.613742 cell lines 0.732784 antineoplaston A10. 0.614589 steady state concentration 0.632482 mean steady state 0.62987 stable disease 0.629423 tumor suppressor genes 0.670419 antineoplaston a10 0.785651 multiple brain metastases 0.666381 clinical trials 0.642258 cancer cell line 0.621623 cancer information summary 0.628466 highest tumor response 0.628298 patients 0.960903 cancer patients 0.782838 average dose 0.662612 human colon cancer 0.66679 tumor progression 0.629611 colon cancer cells 0.664834 antineoplaston treatment 0.679278 complete tumor response 0.726436 metastatic brain tumor 0.711993 study 0.663173 neutrophil apoptosis 0.623745	Human/Clinical Studies section 0.637915 neoplastic cell lines 0.689948 human blood 0.654645 cancer cells 0.75191 animal tumor systems 0.612469 National Cancer Institute 0.656232 tumor growth 0.643714 breast cancer patients 0.772855 partial tumor response 0.663127 AS2-1 0.676129 antineoplaston therapy 0.747438 white blood cell 0.631532 antineoplaston A. 0.675544 abnormal cells 0.630356 human tumor tissue. 0.623365 human urine 0.617971 antineoplastons 0.86378 experimental cancer therapy 0.633011 chronic lymphocytic leukemia 0.610232 tumor response 0.767878 objective tumor response 0.612044 naturally occurring biochemical 0.637098 antineoplastons A10 0.665762 cancer 0.805413	CLICK HERE
1666	National Cancer Institute	Html	en	Testicular Cancer Screening (PDQ®)–Patient Version	Expert-reviewed information summary about tests used to detect or screen for testicular cancer.	testicular self-exams 0.545422 ongoing clinical trials 0.499986 PDQ cancer information 0.758311 testicular cancer 0.955987 testicular germ cell 0.59857 testicular carcinoma 0.546926 NCI Web site 0.507088 testicular cancers 0.553122 clinical trials 0.669739 early detection 0.495849 germ cells 0.505641 cancer information summary 0.64569 clinical trial 0.511819 breast cancer prevention 0.524202 spermatic cord 0.49407 PDQ summaries 0.534816 cancer patients 0.49191 latest published information 0.509374 NCI’s PDQ 0.538459 cancer symptoms 0.51215 NCI PDQ cancer 0.620022 tests 0.527688 testicular cancer screening 0.701295 routine screening test 0.519043	PDQ Screening 0.553678 testicles 0.486139 screening tests 0.48752 Cancer Information Service 0.545478 common cancer 0.501504 male sex glands 0.496865 Prevention Editorial Board 0.56412 treatment clinical trials 0.501604 National Cancer Institute 0.653794 PDQ documents 0.525451 cancer doctors 0.485997 long coiled tube 0.493438 new treatment 0.506259 health professional version 0.485461 Cancer screening trials 0.571582 PDQ database 0.532773 Cancer Care page 0.527585 Testicular Cancer Treatment 0.685082 risk factor 0.499445 PDQ summary 0.654344 routine physical exam 0.576949 cancer information summaries 0.554625 health professional versions 0.489301 comprehensive cancer information 0.555761	CLICK HERE
1716	National Cancer Institute	Html	en	Human Papillomavirus (HPV) Vaccines	A fact sheet about human papillomavirus (HPV) vaccines for the prevention of infection with certain types of HPV, which is the major cause of cervical cancer.	transmitted HPV types 0.372301 HPV prophylactic vaccines 0.352103 anal HPV 0.291899 HPV transmission 0.315597 available HPV vaccine 0.365066 HPV types 0.787213 Disease Control 0.208664 HPV vaccination coverage 0.329587 HPV vaccination program 0.333099 bivalent HPV vaccination 0.335395 hpv vaccination 0.566558 cervical cancer 0.335142 high-risk HPV infections 0.38085 HPV surface components 0.326712 genital HPV infection 0.36709 available HPV vaccines 0.389305 persistent HPV 0.314117 high-risk hpv types 0.523029 HPV vaccines 0.696012 human papillomavirus 0.38319 HPV vaccination series 0.361602 HPV infections 0.517426 genital HPV infections 0.379278 contact.  HPV infections 0.352636 human papillomavirus vaccine 0.256852	hpv infection 0.466234 current HPV vaccines 0.379891 women 0.226009 United States 0.375279 Updated HPV Vaccination 0.330423 current HPV infections 0.328908 therapeutic HPV vaccines 0.356162 human papillomavirus vaccines 0.212379 HPV Vaccination Recommendations 0.367966 Yes. Because HPV 0.297056 dozen high-risk HPV 0.362742 HPV 0.924148 routine HPV vaccination 0.357555 genital warts 0.26905 quadrivalent HPV vaccine 0.329163 additional HPV types 0.3896 quadrivalent human papillomavirus 0.21339 HPV vaccine product 0.372857 additional high-risk HPV 0.343778 currently approved HPV 0.315107 high-risk HPV type 0.392493 Gardasil 0.309437 vaccine-targeted HPV types 0.33361 et al 0.409031	CLICK HERE
1858	National Cancer Institute	Html	es	Tratamiento del cáncer de glándulas salivales (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de glándulas salivales.	salivary gland carcinoma 0.756611 salivary neoplasms 0.424559 estroma linfoide 0.413137 prognostic factors 0.41902 gland tumours 0.43032 Spiro RH 0.465562 Sin embargo 0.429856 advanced salivary 0.421758 Malignant parotid tumors 0.41189 minor salivary 0.423431 tumores benignos 0.597781 Salivary Gland Disease 0.423228 tumores malignos mixtos 0.484605 botulinum toxin 0.428989 Radiat Oncol Biol 0.471433 glándulas salivales benignos 0.570833 neck neoplasia following 0.437258 fuerte predilección 0.414088 Parotid gland tumours 0.420714 salivary gland 0.859636 Head Neck Surg 0.476609 mucoepidermoid carcinoma 0.597885 gland malignant neoplasms 0.445484 tumores benignos mixtos 0.438326 único síntoma 0.425265	parotid gland 0.431427 lesiones carcinoma 0.466113 relativa frecuencia 0.450675 sección carcinoma 0.486375 carcinoma ex-tumor 0.470245 unresectable carcinomas 0.426636 Oral Oncol 0.420027 major salivary glands 0.414421 Otolaryngol Head Neck 0.413034 término carcinoma 0.475993 carcinoma epidermoide 0.472012 edad promedio 0.670934 Salivary Gland Tumours 0.424182 carcinoma with 0.481329 adenocarcinoma sai 0.463524 carcinoma salival basaloide 0.481935 carcinomas quísticos adenoides 0.459095 Botulinum toxin treatment 0.413697 with parotid carcinoma 0.483397 Oncol Biol Phys 0.47266 linfadenoma sebáceo 0.417003 elemento carcinoma 0.475416 carcinoma mucoepidermoide 0.988653 neoplasias benignas 0.45166	CLICK HERE
2037	National Cancer Institute	Html	es	Prevención del cáncer de piel (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre factores que pueden influir en el riesgo de presentar cáncer de piel y sobre las investigaciones dirigidas a prevenir esta enfermedad.	skin cancer 0.991265 cutaneous melanoma 0.469757 Lippincott Williams 0.41932 skin cancer prevention 0.612003 prevent skin 0.440602 protectores solares 0.469609 Williams GM 0.418343 queratosis solares 0.585992 Sin embargo 0.685934 protector solar 0.843096 American Cancer Society 0.553421 Prev Med 0.458565 cancer prevention study 0.448174 case-control study 0.424296 Study Group 0.427125 DeVita VT Jr 0.43478 risk factors 0.435855 with nonmelanoma skin 0.42056 isotretinoin-basal cell carcinomas 0.418488 randomized trial 0.462527 exposición solar 0.710997 Natl Cancer Inst 0.487884 8th ed 0.41947 protección solar 0.624745 melanoma risk factors 0.418328	pruebas insuficientes 0.419855 Nambour Skin Cancer 0.466485 cell carcinomas 0.512878 Halliday GM 0.422507 Arch Dermatol 0.425176 Wilson LD 0.417928 Cancer Facts 0.43005 Aasi SZ 0.421096 nevos melanocíticos benignos 0.418665 protector solar ayuda 0.422241 controlled trial 0.45893 protector solar versus 0.425736 Epidemiol Biomarkers Prev 0.463973 exposición solar aguda 0.467654 Cancer Prevention Trial 0.454925 Thomas VD 0.418204 Reduce Actinic Cancer 0.419285 radiación uv 0.425436 randomized controlled trial 0.440826 radiación solar 0.432514 crema base 0.420169 nonmelanoma skin cancer 0.715174 radiación ultravioleta 0.572893 Cancer Study Group 0.420229	CLICK HERE
4300	National Cancer Institute	Html	en	Cancer Moonshot℠ Blue Ribbon Panel	The Blue Ribbon Panel Report outlines 10 recommendations to accelerate progress against cancer. The panel was established to ensure that the Cancer Moonshot's approaches are grounded in the best science.	BRP 0.544911 National Cancer Advisory 0.917882 pediatric cancer 0.537601 relevant scientific sectors 0.512578 Reduce cancer risk 0.54942 dynamic 3D maps 0.479491 early detection 0.494934 therapeutic targets 0.493364 presidentially appointed National 0.528792 new preclinical models 0.493659 national cancer data 0.584851 previously effective treatments 0.485016 early detection strategies 0.482919 new therapeutic targets 0.480719 cancer resistance 0.471789 E. Intensify research 0.49241 translational science network 0.495254 cancer technologies 0.513048 public idea submission 0.473834 broader cancer community 0.579774 transformative research recommendations 0.554836 cancer immunotherapy network 0.593107 Ribbon Panel report 0.661804 tumor evolution 0.579883	cancer health disparities 0.557334 final recommendations 0.465114 Cancer Immunology 0.464811 human tumor evolution 0.504864 specific recommendations 0.466439 cancer prevention 0.548373 C. Develop ways 0.499508 tumor profile data 0.530939 cancer cells 0.472187 group members 0.429792 Minimize cancer treatment 0.561924 direct patient involvement 0.494413 joint recommendations 0.465939 3D cancer atlas 0.546232 multiple groups 0.44011 Cancer Moonshot Task 0.60025 Blue Ribbon Panel 0.890429 groups 0.493987 BRP members 0.537843 major topic areas 0.508582 Cancer Advisory Board 0.925259 efficient data analysis 0.49446 Develop new cancer 0.562862 future patient outcomes 0.484191	CLICK HERE
17294	National Cancer Institute	Html	es	Anemia	Información y consejos para controlar la anemia, un efecto secundario del tratamiento del cáncer.	suficientes glóbulos 0.941582		CLICK HERE